Caprini VTE Risk Assessment
The Caprini VTE Risk Assessment stratifies perioperative venous thromboembolism risk using weighted patient and procedural risk factors 1 [Level II evidence].
Indications for Use
Used for adult surgical patients to stratify postoperative VTE risk and guide prophylaxis intensity. Validated across specialties, with VTE risk rising sharply at scores ≥7 (meta-analysis, 14 776 patients: high-risk benefit from chemoprophylaxis; OR 0.41–0.60) 1 [Level I evidence]. In critically ill surgical cohorts, VTE increased from 3.5% to 11.5% across score tiers (n=4 844) 2 [Level II evidence]. Clinically used to identify who needs mechanical and/or pharmacologic prophylaxis.
Insights & Cautions
Provides granular surgical VTE stratification but overestimates risk in many low‑acuity patients and shows weak predictive accuracy in unselected hospital cohorts (AUC 0.56) 1 [Level II evidence].
• Strongest validation is in surgery, where VTE rises sharply at ≥7–8 and especially >8 2 [Level II evidence].
• Chemoprophylaxis benefits only at ≥7; no benefit ≤6 3 [Level I evidence].
• Heterogeneous implementation and variable cutoffs reduce reliability 4 [Level II evidence].